Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:145826731" >
Development and val...
Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study
-
Wang, RQ (författare)
-
Xie, GL (författare)
-
Shang, L (författare)
-
visa fler...
-
Qi, CF (författare)
-
Yang, LR (författare)
-
Huang, LY (författare)
-
Li, DY (författare)
-
Yang, WF (författare)
-
visa färre...
- Future Medicine Ltd, 2021
- 2021
- Engelska.
-
Ingår i: Future oncology (London, England). - : Future Medicine Ltd. - 1744-8301 .- 1479-6694. ; 17:8, s. 893-906
- Relaterad länk:
-
https://doi.org/10.2...
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aim: To develop and internally validate nomograms to predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with epithelial ovarian cancer (EOC). Methods: A total of 9001 EOC patients diagnosed between 2010 and 2013 were randomly divided into the training (n = 6301) and validation (n = 2700) cohorts. Nomogram and bootstrap validation were used to assess the predictive values of the models, including discrimination, calibration and clinical benefit. Results: In the validation cohort, the concordance statistic values were 0.733 for OS and 0.747 for CSS. Calibration plots and decision curve analyses demonstrated moderate accuracy and clinical applicability. Conclusion: Nomograms were user-friendly tools for guiding clinical treatment and estimating prognosis.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas